Ignite Creation Date:
2025-12-25 @ 1:27 AM
Ignite Modification Date:
2026-05-15 @ 3:24 PM
Study NCT ID:
NCT01256593
Status:
COMPLETED
Last Update Posted:
2023-09-15
First Post:
2010-12-07
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Safety And Efficacy Of Lyrica (Regulatory Post Marketing Commitment Plan)
Sponsor:
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Neuralgia | View |